HAEMONETICS CORP Quarterly Common Stock, Shares Authorized from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Haemonetics Corp quarterly Common Stock, Shares Authorized history and growth rate from Q1 2010 to Q3 2024.
  • Haemonetics Corp Common Stock, Shares Authorized for the quarter ending September 28, 2024 was 150M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 150M 0 0% Sep 28, 2024 10-Q 2024-11-07
Q2 2024 150M 0 0% Jun 29, 2024 10-Q 2024-08-08
Q1 2024 150M 0 0% Mar 30, 2024 10-Q 2024-11-07
Q4 2023 150M 0 0% Dec 30, 2023 10-Q 2024-02-08
Q3 2023 150M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 150M 0 0% Jul 1, 2023 10-Q 2023-08-08
Q1 2023 150M 0 0% Apr 1, 2023 10-K 2024-05-20
Q4 2022 150M 0 0% Dec 31, 2022 10-Q 2023-02-07
Q3 2022 150M 0 0% Oct 1, 2022 10-Q 2022-11-08
Q2 2022 150M 0 0% Jul 2, 2022 10-Q 2022-08-10
Q1 2022 150M 0 0% Apr 2, 2022 10-K 2023-05-22
Q4 2021 150M 0 0% Jan 1, 2022 10-Q 2022-02-08
Q3 2021 150M 0 0% Oct 2, 2021 10-Q 2021-11-09
Q2 2021 150M 0 0% Jul 3, 2021 10-Q 2021-08-11
Q1 2021 150M 0 0% Apr 3, 2021 10-K 2022-05-25
Q4 2020 150M 0 0% Dec 26, 2020 10-Q 2021-02-02
Q3 2020 150M 0 0% Sep 26, 2020 10-Q 2020-11-04
Q2 2020 150M 0 0% Jun 27, 2020 10-Q 2020-08-04
Q1 2020 150M 0 0% Mar 28, 2020 10-K 2021-05-26
Q4 2019 150M 0 0% Dec 28, 2019 10-Q 2020-02-04
Q3 2019 150M 0 0% Sep 28, 2019 10-Q 2019-11-01
Q2 2019 150M 0 0% Jun 29, 2019 10-Q 2019-08-06
Q1 2019 150M 0 0% Mar 30, 2019 10-K 2020-05-20
Q4 2018 150M 0 0% Dec 29, 2018 10-Q 2019-02-05
Q3 2018 150M 0 0% Sep 29, 2018 10-Q 2018-11-06
Q2 2018 150M 0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 150M 0 0% Mar 31, 2018 10-K 2019-05-22
Q4 2017 150M 0 0% Dec 30, 2017 10-Q 2018-02-06
Q3 2017 150M 0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 150M 0 0% Jul 1, 2017 10-Q 2017-08-07
Q1 2017 150M 0 0% Apr 1, 2017 10-K 2018-05-23
Q4 2016 150M 0 0% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 150M 0 0% Oct 1, 2016 10-Q 2016-11-07
Q2 2016 150M 0 0% Jul 2, 2016 10-Q 2016-08-01
Q1 2016 150M 0 0% Apr 2, 2016 10-K 2017-05-24
Q4 2015 150M 0 0% Dec 26, 2015 10-Q 2016-02-02
Q3 2015 150M 0 0% Sep 26, 2015 10-Q 2015-11-04
Q2 2015 150M 0 0% Jun 27, 2015 10-Q 2015-07-30
Q1 2015 150M 0 0% Mar 28, 2015 10-K 2016-06-01
Q4 2014 150M 0 0% Dec 27, 2014 10-Q 2015-02-05
Q3 2014 150M 0 0% Sep 27, 2014 10-Q 2014-11-04
Q2 2014 150M 0 0% Jun 28, 2014 10-Q 2014-07-31
Q1 2014 150M 0 0% Mar 29, 2014 10-K 2015-05-22
Q4 2013 150M 0 0% Dec 28, 2013 10-Q 2014-01-30
Q3 2013 150M 0 0% Sep 28, 2013 10-Q 2013-10-30
Q2 2013 150M Jun 29, 2013 10-Q 2013-08-02
Q1 2013 150M 0 0% Mar 30, 2013 10-K 2014-05-22
Q4 2012 150M 0 0% Dec 29, 2012 10-Q 2013-02-01
Q3 2012 150M 0 0% Sep 29, 2012 10-Q 2012-11-07
Q1 2012 150M 0 0% Mar 31, 2012 10-K 2013-05-20
Q4 2011 150M 0 0% Dec 31, 2011 10-Q 2012-08-08
Q3 2011 150M 0 0% Oct 1, 2011 10-Q 2011-11-03
Q2 2011 150M 0 0% Jul 2, 2011 10-Q 2011-08-10
Q1 2011 150M 0 0% Apr 2, 2011 10-Q 2012-08-08
Q4 2010 150M Jan 1, 2011 10-Q 2011-02-08
Q3 2010 150M Oct 2, 2010 10-Q 2010-11-10
Q2 2010 150M Jul 3, 2010 10-Q 2010-08-11
Q1 2010 150M Apr 3, 2010 10-K 2011-05-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.